Renalytix plc
RNLXY · RENXF · Services Medical Laboratories
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q3 2024
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Icahn School Of Medicine At Mount Sinai: Form 4
Insider disclosure · Filed · Report period 01 Nov 2024
-
Form 4
SEC filing · Filed
-
Form 10-K
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- G7489R108 · G7489R108 - Ordinary shares, nominal value 0.0025 per share
Company details and SEC sources
CIK 0001811115 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- RNLXY, RENXF on OTC
- SEC industry group
- Services Medical Laboratories (Industrial Applications and Services)
- Business address
- Finsgate, 5 7 Cranwood Street, London
- Incorporated in
- United Kingdom
- Fiscal year end
- 30 June
- Former names on EDGAR
- Renalytix AI plc (to 25 Jun 2021)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields